Truvada trials hold promise for new HIV prevention strategy. Once-a-day might keep HIV away.
D000225:Adenine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D002487:Centers for Disease Control and Prevention, U.S.; D002986:Clinical Trials as Topic; D005260:Female; D015658:HIV Infections / Q000517:prevention & control*; D018023:HIV Seronegativity; D006801:Humans; D008297:Male; D063065:Organophosphonates / Q000008:administration & dosage*; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage*; D000068698:Tenofovir; D014481:United States
D063065:Organophosphonates; D018894:Reverse Transcriptase Inhibitors; D000068698:Tenofovir; D000225:Adenine